- Home
- AERT vs CRIS Comparison
AERT vs CRIS Comparison
Compare AERT & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AERT
- CRIS
- Stock Information
- Founded
- AERT 2012
- CRIS 2000
- Country
- AERT Singapore
- CRIS United States
- Employees
- AERT N/A
- CRIS N/A
- Industry
- AERT Professional Services
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AERT Consumer Discretionary
- CRIS Health Care
- Exchange
- AERT Nasdaq
- CRIS Nasdaq
- Market Cap
- AERT 38.3M
- CRIS 21.3M
- IPO Year
- AERT N/A
- CRIS 2000
- Fundamental
- Price
- AERT $1.04
- CRIS $1.88
- Analyst Decision
- AERT
- CRIS Strong Buy
- Analyst Count
- AERT 0
- CRIS 2
- Target Price
- AERT N/A
- CRIS $16.50
- AVG Volume (30 Days)
- AERT 328.5K
- CRIS 153.9K
- Earning Date
- AERT 08-14-2025
- CRIS 07-31-2025
- Dividend Yield
- AERT N/A
- CRIS N/A
- EPS Growth
- AERT N/A
- CRIS N/A
- EPS
- AERT N/A
- CRIS N/A
- Revenue
- AERT $70,198,000.00
- CRIS $11,202,000.00
- Revenue This Year
- AERT N/A
- CRIS N/A
- Revenue Next Year
- AERT N/A
- CRIS $10.67
- P/E Ratio
- AERT N/A
- CRIS N/A
- Revenue Growth
- AERT N/A
- CRIS 14.17
- 52 Week Low
- AERT $0.46
- CRIS $1.02
- 52 Week High
- AERT $2.93
- CRIS $8.29
- Technical
- Relative Strength Index (RSI)
- AERT 53.28
- CRIS 41.14
- Support Level
- AERT $1.03
- CRIS $1.50
- Resistance Level
- AERT $1.32
- CRIS $1.90
- Average True Range (ATR)
- AERT 0.18
- CRIS 0.20
- MACD
- AERT -0.02
- CRIS -0.06
- Stochastic Oscillator
- AERT 22.40
- CRIS 35.51
About AERT Aeries Technology Inc.
Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.